The two main types, Type 1 and Type 2 Diabetes, differ in cause, but both affect metabolic health
A post-hoc analysis of the four SURMOUNT trials, which included 2,999 women and 1,678 men, found that all doses of tirzepatide produced consistent body weight reductions across both sexes, but women experienced greater percentage weight loss than men
GLP-1 peptides are a great fit for patients struggling with: Obesity Prediabetes Hormonal conditions like PCOS Thyroid issues Managing weight following multiple pregnancies Were active partners in your weight loss journey 01 02 03 Important Medical Disclaimer GLP-1based therapies, including compounded tirzepatide, may assist with weight management but are not appropriate for everyone
Bkdal TA, Borregaard J, Hansen CW, et al